tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ATRC Stock Latest News

AtriCure’s Earnings Call Highlights Robust Growth and Innovation
Company AnnouncementsAtriCure’s Earnings Call Highlights Robust Growth and Innovation
23d ago
ATRC
Atricure’s Strong Q3 Performance and Growth Potential Justify Buy Rating
PremiumRatings
Atricure’s Strong Q3 Performance and Growth Potential Justify Buy Rating
23d ago
ATRC
AtriCure, Inc. Reports Strong Q3 2025 Results
PremiumCompany Announcements
AtriCure, Inc. Reports Strong Q3 2025 Results
24d ago
ATRC
AtriCure reports Q3 EPS (1c), consensus (12c)
PremiumThe Fly
AtriCure reports Q3 EPS (1c), consensus (12c)
24d ago
ATRC
AtriCure sees FY25 EPS (26c)-(23c), consensus (36c)
PremiumThe Fly
AtriCure sees FY25 EPS (26c)-(23c), consensus (36c)
24d ago
ATRC
AtriCure enrolls first patient in BoxX-NoAF clinical trial
PremiumThe FlyAtriCure enrolls first patient in BoxX-NoAF clinical trial
25d ago
ATRC
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance
Premium
Company Announcements
AtriCure’s Ongoing Study: Implications for Cardiac Treatment and Market Performance
26d ago
ATRC
AtriCure’s Cryoablation Study: A New Frontier in Pain Management
Premium
Company Announcements
AtriCure’s Cryoablation Study: A New Frontier in Pain Management
26d ago
ATRC
AtriCure’s TRAC-AF Registry: A Closer Look at Ongoing Clinical Study
PremiumCompany Announcements
AtriCure’s TRAC-AF Registry: A Closer Look at Ongoing Clinical Study
26d ago
ATRC
AtriCure’s BoxX-NoAF Trial: A Step Forward in Cardiac Surgery Innovation
PremiumCompany Announcements
AtriCure’s BoxX-NoAF Trial: A Step Forward in Cardiac Surgery Innovation
26d ago
ATRC
AtriCure’s HEAL-IST IDE Trial: A Promising Step in Treating Inappropriate Sinus Tachycardia
PremiumCompany Announcements
AtriCure’s HEAL-IST IDE Trial: A Promising Step in Treating Inappropriate Sinus Tachycardia
26d ago
ATRC
AtriCure’s Cryoanalgesia Study: A Potential Game-Changer in Post-Operative Pain Management
PremiumCompany Announcements
AtriCure’s Cryoanalgesia Study: A Potential Game-Changer in Post-Operative Pain Management
26d ago
ATRC
ATRC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsATRC Earnings Report this Week: Is It a Buy, Ahead of Earnings?
26d ago
ATRC
AtriCure’s Strategic Growth and Investment Initiatives Drive Buy Rating Amid Market Challenges
Premium
Ratings
AtriCure’s Strategic Growth and Investment Initiatives Drive Buy Rating Amid Market Challenges
3M ago
ATRC
AtriCure Reports Strong Q2 Earnings with Record Growth
Premium
Company Announcements
AtriCure Reports Strong Q2 Earnings with Record Growth
4M ago
ATRC
AtriCure price target raised to $54 from $52 at BTIG
PremiumThe Fly
AtriCure price target raised to $54 from $52 at BTIG
4M ago
ATRC
AtriCure price target raised to $53 from $51 at Canaccord
PremiumThe Fly
AtriCure price target raised to $53 from $51 at Canaccord
4M ago
ATRC
Atricure’s Strong Financial Performance and Growth Prospects Justify Buy Rating
PremiumRatings
Atricure’s Strong Financial Performance and Growth Prospects Justify Buy Rating
4M ago
ATRC
AtriCure’s Strong Q2 2025 Performance and Raised Outlook
PremiumCompany Announcements
AtriCure’s Strong Q2 2025 Performance and Raised Outlook
4M ago
ATRC
AtriCure reports Q2 adjusted EPS (2c), consensus (16c)
PremiumThe FlyAtriCure reports Q2 adjusted EPS (2c), consensus (16c)
4M ago
ATRC
AtriCure cuts FY25 EPS view to (39c)-(34c) from (55c)-(50c), consensus (51c)
Premium
The Fly
AtriCure cuts FY25 EPS view to (39c)-(34c) from (55c)-(50c), consensus (51c)
4M ago
ATRC
ATRC Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
ATRC Earnings this Week: How Will it Perform?
4M ago
ATRC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >